The Deal Register
Database › Equity financing › Doseology Announces $2M Financing to Accelerate Commercialization of…

Equity financing

Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform

Lane
Equity financing
Announced
30 Mar 2026
Province
British Columbia
Industry
Technology
Status
Announced
What the filing says
Doseology Sciences Inc. ( CSE: MOOD | OTCQB: DOSEF | FSE: VU70 ) (" Doseology " or the " Company ") a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it has arranged a non-brokered private placement of up to 3,225,806 units (each, a " Unit ") at a price of $0.62 per Unit to raise aggregate gross proceeds of up to $2,000,000 (the " Offering ").
Terms stated
exercise price, price per security
Source

The terms are in the subscriber edition

This transaction carries 2 stated terms, with the value, unit and basis of each and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe